Literature DB >> 17462694

Variola virus topoisomerase: DNA cleavage specificity and distribution of sites in Poxvirus genomes.

Nana Minkah1, Young Hwang, Kay Perry, Gregory D Van Duyne, Robert Hendrickson, Elliot J Lefkowitz, Sridhar Hannenhalli, Frederic D Bushman.   

Abstract

Topoisomerase enzymes regulate superhelical tension in DNA resulting from transcription, replication, repair, and other molecular transactions. Poxviruses encode an unusual type IB topoisomerase that acts only at conserved DNA sequences containing the core pentanucleotide 5'-(T/C)CCTT-3'. In X-ray structures of the variola virus topoisomerase bound to DNA, protein-DNA contacts were found to extend beyond the core pentanucleotide, indicating that the full recognition site has not yet been fully defined in functional studies. Here we report quantitation of DNA cleavage rates for an optimized 13 bp site and for all possible single base substitutions (40 total sites), with the goals of understanding the molecular mechanism of recognition and mapping topoisomerase sites in poxvirus genome sequences. The data allow a precise definition of enzyme-DNA interactions and the energetic contributions of each. We then used the resulting "action matrix" to show that favorable topoisomerase sites are distributed all along the length of poxvirus DNA sequences, consistent with a requirement for local release of superhelical tension in constrained topological domains. In orthopox genomes, an additional central cluster of sites was also evident. A negative correlation of predicted topoisomerase sites was seen relative to early terminators, but no correlation was seen with early or late promoters. These data define the full variola virus topoisomerase recognition site and provide a new window on topoisomerase function in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462694      PMCID: PMC2705903          DOI: 10.1016/j.virol.2007.02.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation.

Authors:  Y Hwang; D Rhodes; F Bushman
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

Review 2.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 3.  Cellular roles of DNA topoisomerases: a molecular perspective.

Authors:  James C Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2002-06       Impact factor: 94.444

4.  Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome.

Authors:  Chris Upton; Stephanie Slack; Arwen L Hunter; Angelika Ehlers; Rachel L Roper
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Improved microbial gene identification with GLIMMER.

Authors:  A L Delcher; D Harmon; S Kasif; O White; S L Salzberg
Journal:  Nucleic Acids Res       Date:  1999-12-01       Impact factor: 16.971

6.  19F NMR studies of vaccinia type IB topoisomerase. Conformational dynamics of the bound DNA substrate.

Authors:  Keehwan Kwon; Yu Lin Jiang; Fenhong Song; James T Stivers
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

7.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  A poxvirus-like type IB topoisomerase family in bacteria.

Authors:  Berit Olsen Krogh; Stewart Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

9.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

10.  Poxvirus genomes: a phylogenetic analysis.

Authors:  Caroline Gubser; Stéphane Hué; Paul Kellam; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

View more
  8 in total

1.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

2.  Mechanism and specificity of DNA strand exchange catalyzed by vaccinia DNA topoisomerase type I.

Authors:  Mary R Stahley; James T Stivers
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

3.  Diverse energetic effects of charge reversal mutations of poxvirus topoisomerase IB.

Authors:  Helen Jun; James T Stivers
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

Review 4.  Topoisomerases and site-specific recombinases: similarities in structure and mechanism.

Authors:  Wei Yang
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-12       Impact factor: 8.250

5.  Chemical mutagenesis of vaccinia DNA topoisomerase lysine 167 provides insights to the catalysis of DNA transesterification.

Authors:  Lyudmila Yakovleva; Stewart Shuman
Journal:  Biochemistry       Date:  2013-01-23       Impact factor: 3.162

6.  Insights from the structure of a smallpox virus topoisomerase-DNA transition state mimic.

Authors:  Kay Perry; Young Hwang; Frederic D Bushman; Gregory D Van Duyne
Journal:  Structure       Date:  2010-01-13       Impact factor: 5.006

7.  A functional type I topoisomerase from Pseudomonas aeruginosa.

Authors:  Teesta Jain; Benjamin J Roper; Anne Grove
Journal:  BMC Mol Biol       Date:  2009-03-24       Impact factor: 2.946

8.  Variola type IB DNA topoisomerase: DNA binding and supercoil unwinding using engineered DNA minicircles.

Authors:  Breeana G Anderson; James T Stivers
Journal:  Biochemistry       Date:  2014-06-26       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.